072sek
-3,5 %
Date:2025-04-03Time:13:05:25Latest report:Q4-2024List:SpotlightTicker:ACUC
Market Cap:161 msekEnterprise Value:158 msekNet Sales:0,68 msekEarnings:-17,4 msekEmployees:0ISIN:SE0009695927

Ratios

10-year key figure history for AcuCort turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AcuCort with index and moving average MA50 and MA200.

Stockprice:0,72
MA50:0,82
MA200:0,87
Price/MA200:-18,0 %
RSI (14):39,2
Price/MA50:-12,9 %

Description

AcuCort develops and commercializes Dexa ODF - a drug in the form of a fast-dissolving film to apply to the tongue, based on a well-known glucocorticoid - dexamethasone. In the development of Dexa ODF, the benefits of the well-used and documented substance dexamethasone and the fast-dissolving film have been combined in a product that is tailored for quick availability and relief in emergency situations. AcuCort will develop and commercialize Dexa ODF using a global network of licensees and / or distributors. AcuCort will identify, develop and commercialize complementary smart drugs that have a relatively short time to launch and are based on existing substances.

Pharmaceuticals